Warren L. DeSouza

2015

In 2015, Warren L. DeSouza earned a total compensation of $1.7M as Chief Financial Officer at Aimmune Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$76,500
Option Awards$1,423,504
Salary$212,500
Total$1,712,504

DeSouza received $1.4M in option awards, accounting for 83% of the total pay in 2015.

DeSouza also received $76.5K in non-equity incentive plan and $212.5K in salary.

Rankings

In 2015, Warren L. DeSouza's compensation ranked 5,359th out of 13,638 executives tracked by ExecPay. In other words, DeSouza earned more than 60.7% of executives.

ClassificationRankingPercentile
All
5,359
out of 13,638
61st
Division
Manufacturing
1,983
out of 5,187
62nd
Major group
Chemicals And Allied Products
719
out of 1,857
61st
Industry group
Drugs
572
out of 1,531
63rd
Industry
Pharmaceutical Preparations
449
out of 1,179
62nd
Source: SEC filing on April 12, 2016.

DeSouza's colleagues

We found two more compensation records of executives who worked with Warren L. DeSouza at Aimmune Therapeutics in 2015.

2015

Stephen Dilly

Aimmune Therapeutics

Chief Executive Officer

2015

Mary Rozenman

Aimmune Therapeutics

Senior Vice President, Corporate Development and Strategy

In-depth

You may also like